<SEC-DOCUMENT>0000087802-11-000018.txt : 20110914
<SEC-HEADER>0000087802-11-000018.hdr.sgml : 20110914
<ACCEPTANCE-DATETIME>20110914153649
ACCESSION NUMBER:		0000087802-11-000018
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20110913
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20110914
DATE AS OF CHANGE:		20110914

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCIENTIFIC INDUSTRIES INC
		CENTRAL INDEX KEY:			0000087802
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				042217279
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-06658
		FILM NUMBER:		111090516

	BUSINESS ADDRESS:	
		STREET 1:		70 ORVILLE DR
		STREET 2:		AIRPORT INTERNATIONAL PLZ
		CITY:			BOHEMIA
		STATE:			NY
		ZIP:			11716
		BUSINESS PHONE:		6315674700

	MAIL ADDRESS:	
		STREET 1:		70 ORVILLE DR
		CITY:			BOHEMIA
		STATE:			NY
		ZIP:			11716
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sep11.txt
<DESCRIPTION>FORM 8-K FOR SEPTEMBER 14, 2011
<TEXT>
     SECURITIES AND EXCHANGE COMMISSION
           Washington, D.C. 20549


                     FORM 8-K
                  CURRENT REPORT

        PURSUANT TO SECTION 13 OR 15(d)
   OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): September 14, 2011


             SCIENTIFIC INDUSTRIES, INC.
_________________________________________________
(Exact name of registrant as specified in its charter)

Delaware	    000-6658        04-2217279
_______________	  ____________  __________________
(State or other   (Commission    (IRS Employer No.)
jurisdiction of    File Number)
incorporation)

                   70 Orville Drive
                Bohemia, New York 11716
_____________________________________________
   (Address of principal executive offices)


                   (631) 567-4700
__________________________________________________
Registrant's telephone number, including area code


                    Not Applicable
__________________________________________________
(Former name or former address,
if changed since last report)


ITEM 8.01	OTHER EVENTS

On September 13, 2011, the Board of Directors declared a
cash dividend of $.05 per share of Common Stock payable on
November 18,2011 to holders of record as of the close of business
on September 26, 2011.

ITEM 9.01  Financial Statements and Exhibits

(a) and (b) not applicable

(c) Exhibits

Exhibit No.            Exibit
___________            _____________________________
8.01(a)                Press Release dated September 14, 2011.




                            SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                   SCIENTIFIC INDUSTRIES, INC.
                                   (Registrant)


Date:	September 14, 2011
			            By: /s/ Helena R. Santos

			             Helena R. Santos,
			             President and Chief Executive
 			             Officer



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8
<SEQUENCE>2
<FILENAME>div0911.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>
              Scientific Industries, Inc.
                  70 Orville Drive
             Bohemia, New York 11716 USA

FOR IMMEDIATE RELEASE (Bohemia, NY, September 14, 2011)

Scientific Industries Declares a Cash Dividend

September 14, 2010 - Scientific Industries, Inc. (OTCQB: SCND), reported
on Tuesday, September 13, 2011 that its Board of Directors declared a
cash dividend of $.05 per share of Common Stock payable on
November 18, 2011 to holders of record as of the close of business on
September 26, 2011.



About Scientific Industries

Scientific Industries designs, manufactures, and markets a variety of
laboratory equipment, including the world-renowned Vortex-Genie 2 (R)
Mixer, and produces and sells customized catalyst research instruments.
Scientific Industries' products are generally used for research purposes
in laboratories of universities, hospitals, pharmaceutical companies,
chemical companies, and medical device manufacturers.

"Statements made in this press release that relate to future events,
performance or financial results of the Company are forward-looking
statements which involve uncertainties that could cause actual events,
performance or results to materially differ.  The Company undertakes
no obligation to update any of these statements.  Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak as to the date hereof.  Accordingly, any
forward-looking statement should be read in conjunction with the
additional information about risks and uncertainties set forth in
the Company's Securities and Exchange Commission reports, including
our annual report on Form 10-K."

                                ###




</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>